Article: Minogue on AbioCor prospects - 'more optimistic than ever'.

Minogue on AbioCor prospects more optimistic than ever

By CHRISTOPHER DELPORTE

Medical Device Daily Washington Editor

WASHINGTON A day after an FDA panel made an unusual decision regarding the humanitarian device exemption (HDE) application from Abiomed (Danvers, Massachusetts) for its AbioCor totally implantable artificial heart, company leadership told investors it was moving forward with confidence.

Michael Minogue, chairman, president and CEO of Abiomed, said in a Friday conference call that he was more optimistic today than ever before about the devices ultimate marketability and use for heart patients.

On Thursday, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!